Healthcare stocks advanced more than 1% at midday Monday.
CSL (ASX:CSL) gained 1% in recent trade.
On the flip side, the financial sector struggled, shedding more than 2%.
Commonwealth Bank of Australia (ASX:CBA) shares fell past 2% in recent trade.
What else is happening in Asia?
Asia
Aspial Lifestyle's H1 Attributable Profit Surges 88%
Aspial Lifestyle's (SGX:5UF) recorded an 88% rise in attributable profit in the first half of 2026 to SG$52.4 million from SG$27.9 million a year prior.Earnings per share stood at SG$0.0277, up from SG$0.015 previously, according to a Friday filing with the Singapore bourse.Revenue jumped 26% to SG$464.2 million from SG$367.2 million in the year-ago period.
SGX:5UF
Asia
Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug
Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group's Benmelstobart Injection obtained marketing approval from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The approval is for use of the drug in combination with chemotherapy and sequentially followed by Anlotinib Hydrochloride Capsules for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer.
HKG:1177
Asia
Lygend Resources Gets CSRC Nod for China Listed-Share IPO
Lygend Resources & Technology (HKG:2245) obtained approval for its registration application related to its China listed-share initial public offering from the China Securities Regulatory Commission (CSRC).The share offering is subject to various conditions, including certain final regulatory approvals, according to a Friday Hong Kong bourse filing.
HKG:2245